UK markets open in 2 hours 54 minutes

Amedisys, Inc. (AMED)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
92.05+0.21 (+0.23%)
At close: 04:00PM EDT
92.05 0.00 (0.00%)
After hours: 04:27PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.01B
Enterprise value 3.38B
Trailing P/E 23.79
Forward P/E 20.33
PEG ratio (5-yr expected) 1.35
Price/sales (ttm)1.34
Price/book (mrq)2.76
Enterprise value/revenue 1.50
Enterprise value/EBITDA 27.66

Trading information

Stock price history

Beta (5Y monthly) 0.86
52-week change 317.07%
S&P500 52-week change 323.10%
52-week high 396.44
52-week low 373.10
50-day moving average 392.51
200-day moving average 393.11

Share statistics

Avg vol (3-month) 3275.85k
Avg vol (10-day) 3209.73k
Shares outstanding 532.68M
Implied shares outstanding 632.67M
Float 831.95M
% held by insiders 12.26%
% held by institutions 194.98%
Shares short (15 Apr 2024) 42.39M
Short ratio (15 Apr 2024) 48.94
Short % of float (15 Apr 2024) 48.54%
Short % of shares outstanding (15 Apr 2024) 47.31%
Shares short (prior month 15 Mar 2024) 43.12M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 24:3
Last split date 305 Dec 2006

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -0.92%
Operating margin (ttm)9.15%

Management effectiveness

Return on assets (ttm)6.26%
Return on equity (ttm)-1.87%

Income statement

Revenue (ttm)2.25B
Revenue per share (ttm)69.00
Quarterly revenue growth (yoy)2.70%
Gross profit (ttm)N/A
EBITDA 226.54M
Net income avi to common (ttm)-20.59M
Diluted EPS (ttm)-0.64
Quarterly earnings growth (yoy)-43.00%

Balance sheet

Total cash (mrq)108.23M
Total cash per share (mrq)3.31
Total debt (mrq)481.82M
Total debt/equity (mrq)42.17%
Current ratio (mrq)1.09
Book value per share (mrq)33.30

Cash flow statement

Operating cash flow (ttm)104.69M
Levered free cash flow (ttm)243.26M